Dr. Jeffrey E. Godwin, MD

Dr. Godwin practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Dr. Godwin's NPI, 1184604720, was assigned on January 19, 2006. Dr. Godwin graduated from University of Cincinnati College of Medicine in 1985. Dr. Godwin holds New Mexico license MD2009-0045.

Dr. Godwin's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Dr. Godwin's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. Dr. Godwin is also affiliated with Presbyterian Santa Fe Medical Center. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Godwin to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Godwin practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Godwin's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Godwin is licensed in New Mexico.

CMS data shows 330 Medicare services from Dr. Godwin across 9 procedure codes in 2024, for 211 Medicare patients. Medicare paid $34,878 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 211 Medicare patients who saw Dr. Godwin in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Godwin's median patient age at 63, with 47% women.

In 2024, Dr. Godwin wrote 204 Medicare Part D claims for 45 patients. 49% of them were for generic drugs. CMS names the drug for 111 of them, across 5 drugs with 11 or more claims each, at $31,179 in total drug cost. In 2023, CMS named 149 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Godwin for performance year 2024, reported as part of a group. Dr. Godwin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Godwin from 5 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Grifols Shared Services North America, Inc. paid the most, $21.

Dr. Godwin graduated from University of Cincinnati College of Medicine in 1985.